Comparison of the immunogenicity of Cervarix(®) and Gardasil(®) human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33, and HPV-45 in HIV-infected adults

Individuals infected with human immunodeficiency virus (HIV) have excess risk of developing human papillomavirus (HPV)-related disease. A substantial fraction of HPV-associated cancers is caused by HPV serotypes not included in the currently available vaccines. Among healthy women, both Cervarix(®)...

Full description

Saved in:
Bibliographic Details
Published in:Hum Vaccin Immunother
Main Authors: Toft, Lars, Tolstrup, Martin, Müller, Martin, Sehr, Peter, Bonde, Jesper, Storgaard, Merete, Østergaard, Lars, Søgaard, Ole S
Format: Artigo
Language:Inglês
Published: Taylor & Francis 2014
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4896591/
https://ncbi.nlm.nih.gov/pubmed/24553190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.27925
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items